INTRODUCTION
============

The emergence of multidrug-resistant hospital-acquired *Enterococcus faecium* as one of the most important pathogens in the developed world has been a remarkable development in the last two decades ([@r20]; [@r27]). Molecular epidemiological studies and comparative genomic hybridization analyses of *E. faecium* ([@r21]; [@r27]) have revealed genotypic differences between hospital and community isolates ([@r20]). Mixed whole genome arrays demonstrated a distinct genetic make-up of hospital-associated *E. faecium* with more than 100 extra genes, possibly acquired by horizontal gene transfer ([@r21]). The *esp* virulence gene, located on a putative pathogenicity island, is one of the determinants acquired by hospital-associated *E. faecium*. These observations, as well as current multilocus sequence typing (MLST) data, strongly indicate that gene flux and recombination contribute significantly to diversification and adaptation of *E. faecium* ([@r20]; [@r25]).

Recombinases facilitate the exchange of DNA fragments within and between bacteria and are thus pivotal in genome plasticity. Staphylococcal cassette chromosome (SCC) elements are vehicles for exchange of genetic information in staphylococci. These elements are characterized by the presence of terminal inverted repeats and unique recombinase genes, and are flanked by direct repeats ([@r14], [@r15]; [@r18]). So far, the major group of elements described are SCC*mec* I--VIII ([@r12]) responsible for the spread of methicillin resistance between staphylococci. The movement of SCC elements is dependent on the gene products of the cassette chromosome recombinase genes (*ccr*), either the *ccrA*--*ccrB* complex or the single product of *ccrC* ([@r17]; [@r22]). These proteins are serine recombinases of the resolvase/invertase family which integrate the SCC element in a site-specific manner ([@r13]). To our knowledge, *ccr* genes have only been reported in staphylococcal species.

Here, we report for the first time to our knowledge, the presence of *ccrAB* genes in enterococci, hereby designated *ccrAB*~Ent~, and show that they are expressed under standard *in vitro* growth conditions. Our analyses show that the *ccrAB*~Ent~ genes are widely distributed in *Enterococcus* species belonging to the *E. faecium* and *Enterococcus casseliflavus* species groups.

METHODS
=======

Bacterial isolates.
-------------------

A total of 421 *Enterococcus* isolates of 13 species from three continents (Europe, USA and Australia) were included in the study; *E. faecium* (*n*=216), *E. faecalis* (*n*=94), *E. durans* (*n*=38), *E. hirae* (*n*=52), *E. casseliflavus* (*n*=4), *E. avium* (*n*=4), *E. raffinosus* (*n*=3), *E. canintesti* (*n*=2), *E. canis* (*n*=2), *E. gallinarum* (*n*=2), *E. cecorum* (*n*=2), *E. asini* (*n*=1) and *E. dispar* (*n*=1). Among the 216 *E. faecium* isolates, 72 were of human origin of which 58 were clinical isolates. Among the 94 *E. faecalis* isolates, 13 were of human origin of which eight were clinical isolates. Other enterococcal species included were exclusively of animal origin (poultry, dog, bovine and pig). Six ATCC strains were also included. Isolates used for phylogenetic analyses, MLST and/or PCRs to link *ccrAB*~Ent~ with surrounding genes are displayed in Table [1](#t1){ref-type="table"}.

The *E. faecium* ATCC 19434, *E. faecalis* ATCC 29212, *E. gallinarum* ATCC 49608, *E. faecalis* ATCC 19433 and *E. faecalis* ATCC 51575 were used as controls in species identification. All species were identified by *ddl* PCR ([@r9]) or tRNA intergenic spacer PCR ([@r2]).

Detection of *ccrAB*~Ent~ genes in the *E. faecium* DO genome by *in silico* analyses.
--------------------------------------------------------------------------------------

Preliminary sequence data of the *E. faecium* DO strain were obtained from The Joint Genome Institute (JGI) website at <http://genome.jgi-psf.org/mic_home.html> (version 08.06.04). Searches for homologous proteins were performed using [blast]{.smallcaps} 2.0 (<http://www.ncbi.nlm.nih.gov/>, on 8 February 2010) and [fasta]{.smallcaps} 33 (<http://www.ebi.ac.uk/fasta33/>, on 8 February 2010). Translation of coding sequences (CDSs) into amino acid sequences was done using ExPASy proteomic tools (<http://au.expasy.org/tools/>, on 8 February 2010).

For prediction of CDSs we used ORF finder (<http://www.ncbi.nlm.nih.gov/gorf/gorf.html>, on 8 February 2010), Gene Mark (v2.4) ([@r3]), FgenesB (<http://www.softberry.com>, on 2 August 2010) and [artemis]{.smallcaps} (Wellcome Trust Genome Campus, Hinxton, Cambridge, UK). Pairwise comparison and multiple sequence alignments were performed between the *E. faecium* CcrAB~Ent~ proteins and the previously identified four pairs of *Staphylococcus aureus* CcrABs (CcrAB1, CcrAB2, CcrAB3, CcrAB4; GenBank accession nos AB033763, D86934, AB037671 and AF411935) and CcrC (GenBank accession no. AB121219). Since *ccrB1* and *ccrB4* were truncated due to frame shift mutation, 1626 bp (*ccrB1*) and 1629 bp (*ccrB4*) ORFs were reconstituted by adding adenine to deleted positions in order to make the alignment better with the *Staphylococcus hominis ccr* sequence (GenBank accession no. AB063171) which has been fully sequenced ([@r14]). The comparison of DNA sequences was performed in BioEdit v.7.0.5.3 (<http://www.mbio.ncsu.edu/BioEdit/bioedit.html>), while multiple alignments were done using [clustal]{.smallcaps} [w]{.smallcaps} (<http://www.ebi.ac.uk/Tools/clustalw2/index.html>) or T-Coffee (<http://www.ebi.ac.uk/Tools/t-coffee/index.html>).

The evolutionary relationships of CcrAB~Ent~, Ccr of staphylococci (deduced from *ccrA1*, *ccrA2*, *ccrA3*, *ccrA4*, *ccrB1*, *ccrB3*, *ccrB4* and *ccrC*), and three other site-specific recombinases (site-specific integrase of bacteriophage ϕ-FC1 found in *E. faecalis* and two site-specific recombinases from *Clostridium acetobutylicum* ATCC824) were further investigated. These were included because they have been part of previous similar analyses ([@r15]) and because the *ccrA* and *ccrB*, as well as one of the recombinases from *C. acetobutylicum* (AE001437; locus tag no. CAC 2247), have been annotated as if they were DNA invertase Pin homologue proteins. The full-length *ccrB1* of NCTC10442 and *ccrB4* of HDE288 were reconstituted as described earlier ([@r15]). A neighbour-joining tree was constructed using [mega]{.smallcaps}3 ([@r19]) by creating 2000 bootstrap replicates. Sites with gaps/missing data were excluded during analyses. Recombination within the sequenced regions of *ccrA*~Ent~ and *ccrB*~Ent~ was determined by phi test ([@r4]).

Protein structures were predicted using [pstpred]{.smallcaps} v2.4 (<http://bioinf.cs.ucl.ac.uk/psipred/>, on 17 December 2008) and the determinations of protein superfamilies were done using the HMM library, Genome assignment v1.65 (<http://supfam.mrc-lmb.cam.ac.uk/SUPERFAMILY/>, on 8 February 2010), InterProscan (<http://www.ebi.ac.uk/InterProScan/>, on 8 February 2010) and Pfam (<http://pfam.sanger.ac.uk/>, on 8 February 2010). The programs EditSeq and SeqMan ([dnastar]{.smallcaps}) were used for sequence analysis. To detect repeat sequences, Nucleic Acid Dot Plot (<http://arbl.cvmbs.colostate.edu/molkit/dnadot/index.html>, on 17 June 2010) and the Dotlet database (<http://myhits.isb-sib.ch/cgi-bin/dotlet>, on 8 February 2010) were used.

DNA extraction, PCR amplification and DNA sequencing.
-----------------------------------------------------

Bacterial DNA extraction for PCR analyses was performed manually by using the InstaGene matrix kit (Bio-Rad) or the GenoM-48 robotic workstation using GenoPrep DNA from blood, standard kit (Genovision). DNA for hybridization purposes was isolated using guanidium isothiocyanate ([@r6]).

For long range PCR, 2 U DNA polymerase enzyme r*Tth* XL (Perkin Elmer) was used per reaction and 1.4 mM Mg(OAc)~2~ in a standard XL PCR mix, or a 0.7× *Pfu* Ultra mix (Stratagene) with 2.5 U *Pfu* Ultra polymerase per reaction. DNA sequencing was performed using BigDye 3.1 technology (Applied Biosystems). Real-time PCR was performed using ABI Prism 7300 real-time PCR system (PE Biosystems) and *Taq*Man universal mastermix (Applied Biosystems).

Detection of *ccrAB*~Ent~ genes and PCR linkage to surrounding genes.
---------------------------------------------------------------------

*ccrAB*~Ent~ genes were detected by PCR, using the primer pairs FA--RA and FB--RB, respectively (Table [2](#t2){ref-type="table"}), and genes in selected isolates were detected by Southern hybridization and DNA sequencing. PCRs were also performed on 13 of 14 *ccrAB*~Ent~-positive *E. faecium* isolates selected for MLST as well as two *ccrAB*~Ent~-positive *E. faecium* animal isolates from Norway, to search for the presence and conservation of gene synteny in the surrounding genes (Table [2](#t2){ref-type="table"} and Fig. [1a](#f1){ref-type="fig"}). Primers and probes were designed using *E. faecium* DO sequences as template.

Expression analysis of *ccrAB*~Ent~ genes by real-time quantitative PCR.
------------------------------------------------------------------------

To analyse if *ccrAB*~Ent~ genes are expressed, *E. faecium* DO was grown aerobically in BHI broth at 37 °C for 18--24 h. Subsequently the culture was diluted 1 : 50 in BHI broth and grown with agitation to OD~600~ 0.7 or to stationary phase (grown overnight). The cell suspension was centrifuged and the cells were immediately frozen on dry ice or liquid nitrogen before adding an RNA stabilizing solution, RNA later (Ambion). Alternatively, RNA later or RNA protect (Qiagen) was added directly to the inoculum, according to the manufacturer\'s instructions. RNA extraction was performed by using the RNeasy mini kit (Qiagen) using a prolonged lysis step of 45 min with 10 mg lysozyme and 10 U mutanolysin in a total volume of 100 μl. On-column DNase treatment was performed according to the manufacturer\'s instructions. A successive removal of DNA was performed using Turbo DNase (Ambion) according to the manufacturer\'s instructions. RNA integrity was determined by agarose gel electrophoresis. Reverse transcription of the total RNA was performed using the ABRTR1 primer and the High Capacity cDNA Reverse Transcription kit (Applied Biosystems) or Superscript III RNase H-reverse transcriptase (Invitrogen). Real-time PCR was performed on the cDNA using primers ccrAFre, ccrARre, ccrBFre, ccrBRre, recAFre, recARre, pbp5Fre, pbp5Rre, adkFre and adkRre, and probes ccrA~Ent~, ccrB~Ent~, recA, pbp5 and adk (Table [2](#t2){ref-type="table"}). Expression of *ccrAB*~Ent~ genes was compared with the expression of *recA*, *pbp5* and *adk*. Ten-fold serial dilutions of *E. faecium* DO genomic DNA were used to make standard curves to determine PCR efficiency, using the equation: E=10^(−1/slope)^−1. The PCR efficiencies ranged from 88 to 104 % in one assay and 99 to 100 % in a second assay and were considered similar enough to be able to compare only *C~t~* (threshold cycle) values for a semiquantitative relative measurement of expression. The expression experiments were performed in three triplicates; a no template control (NTC) and a minus reverse transcriptase control (−RT) was included in each assay. The −RT controls were in the range of an acceptable difference from the cDNA expression analysis (\>5*C~t~* difference).

Analysis of *ccrAB*~Ent~ mRNA linkage by RT-PCR.
------------------------------------------------

RNA isolation was performed as described above. RNA was treated with the DNA-free kit (Ambion). Reverse transcription of total RNA was performed with SuperScript III reverse transcriptase (Invitrogen) using primers CcrBRTR1 or CcrBxR. RT-PCR without reverse transcriptase was performed on total RNA to check for DNA contamination. Linkage of *ccrA*~Ent~ and *ccrB*~Ent~ mRNAs as a bicistronic mRNA was analysed by PCRs on cDNAs using primers located in *ccrA*~Ent~ (CcrARTR1 and CcrAxF) and *ccrB*~Ent~ (CcrBRTR1 and CcrBxR) (Fig. [1b](#f1){ref-type="fig"} and Table [2](#t2){ref-type="table"}).

Southern blot hybridization analyses.
-------------------------------------

RFLP with *Xba*I (Promega) was performed on total genomic DNA for selected *E. faecium* isolates (DO, TUH7-55, E0470, E0745, E1304 and E1293). PFGE of *Sma*I-digested DNA from 76 *E. faecium* isolates was performed as described by [@r7]. DNA fragments separated by gel electrophoresis were transferred to a positively charged nylon membrane (Boehringer) by vacuum blotting using a Vacugene XL system (Amersham Biosciences). Southern blot hybridization was performed with a DIG-labelled (Boehringer) *ccrA*~Ent~ probe based on *E. faecium* DO.

MLST.
-----

MLST was performed on a subset of isolates using the following primers: adk1n, adk2n, atpA1n, atpA2n, ddl1, ddl2, gdh1, gdh2, gyd-1, gyd2, pstS1n, pstS2, purK1n and purK2n ([@r11]).

RESULTS AND DISCUSSION
======================

*ccrAB*~Ent~ sequences in the *E. faecium* DO genome
----------------------------------------------------

Genes similar to the *ccrA* and *ccrB* genes of *S. aureus* (GenBank accession no. D86934) were identified in the draft sequence of the *E. faecium* DO genome. [blast]{.smallcaps} searches indicated two CDSs (locus tag nos 2319 and 2398) in *E. faecium* DO contig 655 (version 08.06.04) similar and in an identical order to the staphylococcal *ccrA* and *ccrB*. They were named *ccrA*~Ent~ and *ccrB*~Ent~. No available reports have previously shown *ccrA*~Ent~ and *ccrB*~Ent~ genes in enterococci. The *ccrA*~Ent~ and *ccrB*~Ent~ CDSs are 1374 bp and 1638 bp in size, respectively. The two *ccrAB*~Ent~ genes in *E. faecium* DO were similar in length to the staphylococcal *ccrAB2* ([@r17]).

The *ccrAB*~Ent~ gene synteny was confirmed to be the same as in staphylococci ([@r17]) for 14 of 15 *E. faecium* isolates by linkage PCR (Table [3](#t3){ref-type="table"}). No available results have previously shown whether staphylococcal *ccrA* and *ccrB* genes are transcribed as separate units or as a bicistronic mRNA. RT-PCR analysis of total RNA from *E. faecium* DO revealed that the *ccrAB*~Ent~ genes were transcribed as a bicistronic mRNA, confirming the bioinformatics results. Knowing the function of *ccrAB* in staphylococci, we hypothesize that *ccrAB*~Ent~ genes in enterococci might be part of a larger integrative genetic element in *E. faecium*. The GC content of *E. faecium* DO contig 655 (35 %), the *ccrAB*~Ent~ CDSs (35 %) and the whole genome (38 %) is not substantially different. No putative termini (repeats) were identified in contig 655 by nucleic acid dot plot or DotLet analyses. Thus it was not possible to identify a putative integrative element. The genome sequence of contig 655 is limited to the *tnp* transposase determinant (Fig. [1a](#f1){ref-type="fig"}) at the left side and it has not been possible to identify the continuation of this sequence in another DO contig. The sequence at the other side of *ccrAB*~Ent~ also contains a lot of putative transposases (belonging to several insertion sequence families) in addition to hypothetical proteins (<http://maple.lsd.ornl.gov/cgi-bin/JGI_microbial/contig_viewer.cgi?org=efae&chr=08jun04&contig=Contig655&sort=left_bp>, on 21 June 2010) which may well be part of an integrative element.

Pairwise comparison and multiple sequence alignments were performed between the *E. faecium* CcrAB~Ent~ proteins and the Ccr proteins of *S. aureus*. The similarities of CcrA and CcrB between *E. faecium* and *S. aureus* N315 were 55 and 69 %, respectively. The N-terminal resolvase and recombinase domains, as well as the predicted catalytic serine residue of the recombinase active site were highly conserved between the *Staphylococcus* and *Enterococcus* CcrAB proteins. Moreover, the *Enterococcus* CcrB~Ent~ was predicted to include an Ogr/delta-like domain (a phage transcription activator). Two algorithms, Pfam and ProScan, predicted both the resolvase and recombinase domains in the examined Ccr protein sequences (Supplementary Table S1, available with the online version of this paper).

The evolutionary relationships of CcrAB~Ent~, Ccr of staphylococci and three other site-specific recombinases were further investigated. The phylogenetic analyses revealed an evolutionary relationship between CcrA~Ent~ and CcrB~Ent~ from enterococci and the staphylococcal CcrAB cluster (Fig. [2](#f2){ref-type="fig"}). However, the low identity score between the enterococcal and staphylococcal proteins does not support a recent horizontal transfer of the *ccr* genes between these species.

*ccrAB*~Ent~ genes are expressed in *E. faecium*
------------------------------------------------

Analyses of *ccrAB*~Ent~ gene expression were performed during both the exponential and stationary phase of *E. faecium* DO grown in rich medium. Both genes were expressed in approximately the same amounts in exponential phase. *ccrAB*~Ent~ genes were expressed \>70-fold lower than the *pbp5*, *recA* and *adk* genes (Supplementary Fig. S1). The mRNA abundance of *ccrAB*~Ent~ was lower in stationary phase than in exponential phase.

*ccrAB*~Ent~ genes are dispersed among *Enterococcus* species belonging to the *E. faecium* and *E. casseliflavus* species groups
---------------------------------------------------------------------------------------------------------------------------------

Of a total of 421 enterococcal isolates, 118 (28 %) were positive for *ccrAB*~Ent~ genes in five species by PCR; *E. faecium* (58/216, 27 %), *E. durans* (31/38, 82 %), *E. hirae* (27/52, 50 %), *E. casseliflavus* (1/4, 25 %) and *E. gallinarum* (1/2, 50 %) (Table [1](#t1){ref-type="table"}). One *E. hirae* isolate was positive by PCR for *ccrB*~Ent~ only. Eight other species including *E. faecalis* were negative for *ccrAB*~Ent~ (data not shown).

A [blast]{.smallcaps} search for the *ccrAB*~Ent~ genes and the surrounding regions against *Enterococcus* strains revealed the presence of *ccrAB*~Ent~ in *E. faecium* E1071, 1,231,408 and C68 (<http://www.ncbi.nlm.nih.gov/genomes/geblast.cgi?gi=6512#SearchSet>, on 21 June 2010) and no *ccrAB*~Ent~ sequence or protein matches with high identity scores in other available *Enterococcus* genomes (<http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi>, on 21 June 2010). *E. faecium* E1071 and *E. faecium* 1,231,408 showed sequence similarity with the DO sequence in parts of the hypothetical protein, *ccrB*~Ent~ and parts of *ccrA*~Ent~. *E. faecium* C68 showed similarity with DO in parts of the hypothetical protein, both *ccrA*~Ent~ and *ccrB*~Ent~ and parts of the replication initiation factor (REP factor).

*ccrAB*~Ent~ gene sequences (GenBank accession nos FJ572967--FJ573039) from *E. faecium* (*n*=14), *E. hirae* (*n*=10 for *ccrA*~Ent~ and 11 for *ccrB*~Ent~), *E. durans* (*n*=10), *E. gallinarum* (*n*=1) and *E. casseliflavus* (*n*=1) isolates were aligned and a neighbour-joining phylogenetic tree was made with 2000 bootstrap replicates using the P-distance model (Fig. [3](#f3){ref-type="fig"}). The *ccrAB*~Ent~ genes both clustered into two major clades represented by the majority of *E. faecium* (clade I) and *E. hirae* (clade II) isolates, respectively. With 7 of 10 isolates clustering in clade II, *E. hirae* appears to be slightly more dispersed between the two *ccrA*~Ent~ clades. *ccrAB*~Ent~ from the *E. gallinarum* and *E. casseliflavus* isolates clustered in clade II with the majority of *ccrAB*~Ent~ from the *E. hirae* isolates. In *E. durans*, 6 of 10 *ccrA*~Ent~ genes clustered in clade I, while 7 of 10 *ccrB*~Ent~ clusters were in clade II. Except for *ccrA*~Ent~ from *E. faecium* E1304, the *ccrAB*~Ent~ genes of the human isolates clustered in clade I whereas the animal isolates were found in both clades. Incongruence between *ccrA*~Ent~ and *ccrB*~Ent~ phylogenies within an isolate was noted for 11 isolates, all of animal origin (Fig. [3](#f3){ref-type="fig"}, isolates marked with asterisks). Phi tests revealed no statistically significant evidence for recombination within the sequenced regions of the *ccrA*~Ent~ and *ccrB*~Ent~ genes. However, the incongruence suggests recombination of the *ccr*~Ent~ genes outside the sequenced regions of the two genes. Incongruence between these genes has also been seen for *S. aureus* ([@r15]).

*ccrAB*~Ent~ genes were only found in isolates belonging to the *E. faecium* and *E. casseliflavus* species groups that belong to the same tree branch in phylogenetic trees based on enterococcal 16S and *sodA* gene diversity ([@r8]; [@r24]). The absence of *ccrAB*~Ent~ in the other species could be explained by the low number of isolates tested, except for *E. faecalis*, or by a lack of integration sites recognized by *ccrAB*~Ent~ in the strains not belonging to the *E. faecium* or *E. casseliflavus* groups. Alternatively, their *ccrAB*~Ent~ genes may exhibit such a low sequence identity to the *ccrAB*~Ent~ genes identified in this study that they are missed using the PCR and hybridization conditions used in the present study.

Variations of the *ccrAB*~Ent~ genes and the surrounding region between selected *E. faecium* isolates
------------------------------------------------------------------------------------------------------

PFGE analysis and Southern hybridization of 76 *E. faecium* isolates with the *ccrA*~Ent~ probe confirmed the PCR results. One *ccrA*~Ent~ PCR-negative strain (399/F98/A1) was *ccrA*~Ent~-positive by Southern blot hybridization (data not shown) indicating that sequence diversity affects PCR amplification. Also, *Xba*I analyses of *ccrA*~Ent~ and *ccrB*~Ent~ genomic regions revealed heterogeneity and only one copy of *ccrA*~Ent~. The *ccrA*~Ent~ probe hybridized to an approximately 10 kb fragment in DO, TUH7-55, E1304 and E1293 isolates; however, the *ccrA*~Ent~-positive fragment of E0470 and E0745 was approximately 24 kb (data not shown). To investigate this in more detail, the presence of *ccrAB*~Ent~ flanking genomic genes identified in the DO genome was determined by multiple PCRs in 15 *ccrAB*~Ent~-positive and 16 *ccrAB*~Ent~-negative isolates (Fig. [1a](#f1){ref-type="fig"}). Examinations of the *ccrAB*~Ent~ surrounding region in several isolates showed a variable pattern of the *ccrAB*~Ent~ flanking sequences with hospital-associated isolates showing most sequence similarity with the DO sequence (Table [3](#t3){ref-type="table"}). All 31 isolates were positive for the *tnp* gene-specific PCR (*tnp* belongs to the IS*30* family) as well as for orf1 PCR and three *ccrAB*~Ent~-positive isolates of different sequence types (STs) were also positive for the REP factor gene PCR. This REP factor gene harbours a REP\_*trans* domain belonging to superfamily pfam02486. This family represents probable topoisomerases that makes a sequence-specific single stranded nick in the origin of replication. Plasmid REPs, phage REPs (RstAs) and transposon REPs (Cro/CI transcriptional regulators) belong to this family. Long-range PCRs confirmed linkage of these genes with *ccrAB*~Ent~ and conservation of gene synteny surrounding *ccrAB*~Ent~ with the exception of isolates 64/F99/H6, 399/F99/A10, 399/F99/H8, and S399/F99/A14, for which linkage of *tnp*--orf1 and orf1--*ccrB*~Ent~ was not confirmed. Furthermore, a *ccrB*~Ent~--*ccrA*~Ent~ linkage was not shown in 64/F99/H6 (Table [3](#t3){ref-type="table"} and Fig. [1a](#f1){ref-type="fig"}). The inability to link genes that were positive on gene-specific PCRs may indicate that the region between these genes is larger than expected or that the specific genes are located at other regions in the genome. The transposase of the IS*30* family is, for instance, located at more than one site in *E. faecium* DO. Annotation of contig 655 (<http://maple.lsd.ornl.gov/cgi-bin/JGI_microbial/contig_viewer.cgi?org=efae&chr=08jun04&contig=Contig655&sort=left_bp>, on 21 June 2010) also indicates that the *ccrAB*~Ent~ genes are located in a region containing several transposases. The regions surrounding *ccrAB* in staphylococci contain highly variable genes encoding ORFs of unknown functions. These variable regions are called J1 and J2, and variations in these regions are used to define the SCC*mec* subtypes ([@r12]), and so our results from enterococci are in line with these observations of highly variable regions surrounding *ccrAB* in staphylococci. CcrA and CcrB have roles in the excision and integration of SCC*mec* in staphylococci ([@r26]) and we have showed that the *ccrAB*~Ent~ genes are expressed in *E. faecium* DO. It has been postulated that SCC may carry the genes conferring methicillin resistance but may also enable genetic exchange of other genes among staphylococcal species ([@r18]). However, to our knowledge, no studies have provided direct experimental evidence for intercellular transfer of SCC between staphylococci.

DNA sequencing of the *ccrAB*~Ent~, *tnp* and *orf1* of the 15 *ccrAB*~Ent~-positive isolates showed 94--100 % and 96--100 % sequence identity in *ccrA*~Ent~ and *ccrB*~Ent~ genes (GenBank accession nos FJ572978--FJ572981, FJ572997--FJ573001, FJ573014--FJ573018, FJ573032--FJ573036), respectively, while sequences of *orf1* and *tnp* were 100 % identical in all isolates (data not shown). According to [@r10], up to 4 % variation within the *ccrAB* genes has been observed for a given staphylococcal species. The *ccrAB* genes found in SCC*mec* types II and IV can vary up to 5 % at the nucleotide level ([@r22]). Since both *ccrAB*~Ent~ genes and the staphylococcal *ccrAB* genes show sequence variations within the recombinase genes, which have the same gene synteny and variable surrounding regions, we hypothesize that they may have similar functions in contributing to excision and integration of surrounding genes within the genome and possibly also mobilization of surrounding genes between cells.

Investigation of possible association between *ccrAB*~Ent~ and ST within *E. faecium* of human origin
-----------------------------------------------------------------------------------------------------

MLST analyses of *E. faecium* isolates (*n*=39) revealed that the *ccrAB*~Ent~ genes are dispersed among different STs (Table [1](#t1){ref-type="table"}). Ten of 29 (34 %) hospital-related *E. faecium* isolates were *ccrAB*~Ent~-positive, while 4 of 10 (40 %) non-hospital-related isolates were positive. Furthermore, specific STs within hospital-related strains were represented by both *ccrAB*~Ent~-positive and -negative isolates (Table [1](#t1){ref-type="table"}), suggesting that *ccrAB*~Ent~ genes are acquired and not a part of the core genome.

Concluding remarks
------------------

Cassette chromosome recombinases may be important in recombination and genome plasticity in enterococci. Expression analyses indicate that the recombinase genes are active in *E. faecium* DO and thus, may play a role in the recombination or movement of genetic elements. Further investigation of the *ccrA*~Ent~ and *ccrB*~Ent~ will be essential to reveal the contribution of these genes for recombination and mobilization events in enterococci.

-   **s:** ATCC, American Type Culture Collection

-   CDSs, coding sequences

-   JGI, Joint Genome Institute

-   MLST, multilocus sequence type

-   ST, sequence type

-   SCC, staphylococcal cassette chromosome
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A supplementary figure, showing representative real-time PCR results for the expression of five genes, and a supplementary table, showing the domains for Ccr~Ent~ proteins predicted in the Pfam database, are available with the online version of this paper.

![(a) Schematic presentation of the *ccrAB*~Ent~ region of *E. faecium* DO and the long-range PCRs used to link genes surrounding the *ccrA*~Ent~ and *ccrB*~Ent~ genes in *E. faecium*. (b) Schematic presentation of *ccrAB*~Ent~, indicating the positions of the PCR primers used for mRNA linkage. Linkage of *ccrA*~Ent~ and *ccrB*~Ent~ mRNAs was performed using combinations of primers ccrAxF/ccrBRTR1, ccrAxF/CcrBxR, CcrARTF1/ccrBRTR1 and CcrARTF1/ CcrBxR.](3624fig1){#f1}

![Phylogram for CcrA~Ent~, CcrB~Ent~, other Ccrs, and three site-specific recombinase proteins. The deduced amino acid sequences of the following genes were used: *ccrA1* and *ccrB1\** (from NCTC10442, GenBank accession no. AB033763); *ccrA2* and *ccrB2* (from N315, GenBank accession no. D86934); *ccrA3* and *ccrB3* (from 85/2082, GenBank accession no. AB037671); *ccrA4* and *ccrB4\** (from HDE288, GenBank accession no. AF411935); *ccrC* \[from JSCC 3624 (WIS), GenBank accession no. AB121219\]; site-specific integrase (from phi-FC1, GenBank accession no. AF124258); and two site-specific recombinases (from *C. acetobutylicum* ATCC824, GenBank accession no, AE001437, locus tag nos CAC 1228 and CAC 2247). The scale bar indicates genetic distance in substitutions per site. The Ccr clusters are circled. The amino acid sequences were aligned using T-Coffee. The neighbour-joining phylogenetic tree was constructed with [mega]{.smallcaps}3 from 2000 bootstrap replicates using the P-distance model. The dataset consisted of 447 amino acids with 37 parsimony-informative sites for CcrA and 547 amino acids with 50 parsimony-informative sites for CcrB.](3624fig2){#f2}

![Phylogram for *ccrA*~Ent~ and *ccrB*~Ent~ genes. The nucleotide sequences for *ccrA*~Ent~ and *ccrB*~Ent~ genes from *E. faecium* (*n*=15), *E. hirae* (*n*=10/11), *E. durans* (*n*=10), *E. casseliflavus* (*n*=1) and *E. gallinarum* (*n*=1) were used (GenBank accession nos FJ572967--FJ573039). Upper case letters in parentheses represent the origin of the isolate: (C), chicken; (H), human; (D), dog; (P), pig; and (A), unknown animal origin. Outgroups are represented by *S. aureus* N315 *ccrA* and *ccrB* (GenBank accession no. D86934). The asterisks indicate isolates in which *ccrA*~Ent~ and *ccrB*~Ent~ belong to different clades. All sequences were aligned using [clustal]{.smallcaps} [w]{.smallcaps}. The neighbour-joining phylogenetic tree was made with [mega]{.smallcaps}4.0 using 2000 bootstrap replicates and the P-distance model. Bootstrap values higher than 80 % are shown at the branches. The scale bar indicates genetic distance in substitutions per site. The two main clades of *ccrA*~Ent~ and *ccrB*~Ent~ are indicated. The dataset consisted of 547 nt with 494 parsimony-informative sites for *ccrA*~Ent~ and 513 nt with 227 parsimony-informative sites for *ccrB*~Ent~.](3624fig3){#f3}

###### 

*Enterococcus* isolates selected for MLST typing, phylogenetic analyses and/or PCRs to link *ccrAB*~Ent~ with surrounding genes

Type of vancomycin resistance, ST or hospital-related ST (CC17 genogroup), and the presence of *ccrAB*~Ent~ genes is shown. [nd]{.smallcaps}, not determined; −, negative.

  **Isolate name**         **Origin country/region**   **Sample source**        **Epidemiology\***   ***van* type**     **ST**             ***ccrAB*~Ent~**   **Reference/source**
  ------------------------ --------------------------- ------------------------ -------------------- ------------------ ------------------ ------------------ ---------------------------
  ***E. faecium***                                                                                                                                            
  C68                      USA/Ohio                    Human faeces             CI                   *vanB*             16 (CC17)          AB                 [@r5]
  E0470                    Netherlands/Amsterdam       Human blood              HO                   *vanA*             16 (CC17)          AB                 [@r28]
  E0734                    Netherlands/Amersfoort      Hospital faeces          HO                   *vanA*             16 (CC17)          AB                 [@r28]
  E0745                    Netherlands/Utrecht         Human faeces             HO                   *vanA*             16 (CC17)          AB                 [@r28]
  TUH7-15                  USA                         Human blood              HO                   *vanB*             16 (CC17)          AB                 [@r7]
  E0510                    Australia/Melbourne         Human blood              HO                   *vanB*             17 (CC17)          −                  [@r28]
  TUH2-18                  Norway/Bergen               Human urine              HO                   *vanB*             17 (CC17)          −                  [@r7]
  TUH2-19                  Norway/Bergen               Human wound              HO                   *vanB*             17 (CC17)          −                  [@r7]
  TUH7-55                  Germany                     Human urine              CI                   *vanB*             17 (CC17)          AB                 [@r7]
  DO (TX0016)              USA/Houston                 Human blood              CI                   −                  18 (CC17)          AB                 [@r1]
  E1652                    Netherlands/Amersfoort      Human faeces             HO                   *vanA*             18 (CC17)          −                  [@r28]
  E1406                    Spain/Madrid                Human blood              HP                   [nd]{.smallcaps}   63 (CC17)          −                  T M. Coque/R. Willems
  E1392                    Great Britain/Centre H      Human                    HP                   [nd]{.smallcaps}   64 (CC17)          −                  N. Woodford/R. Willems
  E1181                    Austria/Linz                Human blood              HP                   [nd]{.smallcaps}   78 (CC17)          −                  ENARE/R. Willems
  E1186                    Germany                     Human blood              HP                   [nd]{.smallcaps}   78 (CC17)          −                  ENARE/R. Willems
  E1321                    Italy/Rome                  Human catheter           HP                   [nd]{.smallcaps}   78 (CC17)          −                  L. Baldassarri/R. Willems
  E1644                    Germany/Freiburg            Human catheter urine     HP                   [nd]{.smallcaps}   78 (CC17)          −                  D. Jonas/R. Willems
  E0333                    Israel/Centre1              Human blood              HP                   [nd]{.smallcaps}   80 (CC17)          −                  R. Schouten/R. Willems
  E1775                    Belgium                     Pig faeces                                    [nd]{.smallcaps}   121 (CC17)         AB                 E. de Leener/R. Willems
  E1173                    Portugal/Coimbra            Human wound              CI                   *vanA*             125 (CC17)         −                  [@r28]
  E1304                    Portugal/Coimbra            Human blood              CI                   *vanA*             132 (CC17)         AB                 [@r28]
  E1762                    Australia/Perth             Human                    Hospital survey      [nd]{.smallcaps}   174 (CC17)         −                  W. Grubb/R. Willems
  U0105                    Netherlands                 Human blood              HP                   [nd]{.smallcaps}   267 (CC17)         −                  A. Troelstra/R. Willems
  3332                     USA/Ohio                    Human                    HO                   *vanB*             308 (CC17)         AB                 [@r5]
  TUH4-65                  USA                         Human                    CI                   *vanB*             313 (CC17)         −                  [@r7]
  E0125                    Netherlands/Rotterdam       Human bile               CI                   *vanA*             5                  −                  [@r28]
  399/F98/H2               Norway/Østfold              Human faeces             CS                   *vanA*             8                  −                  [@r16]
  64/3                     Germany                     Human faeces             HP                   −                  21                 −                  [@r27]
  E0073                    Netherlands/Rotterdam       Human faeces             CI                   *vanA*             22                 −                  [@r28]
  S399/S99/H5              Norway/Østfold              Human faeces             CS                   −                  48                 −                  [@r16]
  64/F98/H1                Norway/Østfold              Human faeces             CS                   *vanA*             48                 −                  [@r16]
  E1293                    Italy/Geneva                Human blood              CI                   −                  50                 AB                 [@r28]
  E1626                    Netherlands                 Human peritoneal fluid   CI                   −                  92                 −                  [@r28]
  BM4105-RF                France                      Human faeces             Wild strain          −                  172                −                  [@r23]
  399/F99/H8               Norway/Østfold              Human faeces             CS                   *vanA*             195                AB                 [@r16]
  64/F99/H6                Norway/Østfold              Human faeces             CS                   *vanA*             246                AB                 [@r16]
  399/F99/A10              Norway/Østfold              Animal faeces            CS                   *vanA*             310                AB                 [@r16]
  399/F98/A1               Norway/Østfold              Animal faeces            CS                   *vanA*             311                −†                 [@r16]
  S399/F98/H3              Norway/Østfold              Human faeces             CS                   −                  312                −                  [@r16]
  K17a                     Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  K40b                     Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  S399/S99/A4              Norway/Østfold              Animal faeces            CS                   −                  [nd]{.smallcaps}   AB                 [@r16]
  S399/F99/A14             Norway/Østfold              Animal faeces            CS                   −                  [nd]{.smallcaps}   AB                 [@r16]
  V63b                     Belgium                     Pig                                           [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  V128                     Belgium                     Pig                                           [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  ***E. durans***                                                                                                                                             
  K101b                    Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  K4a                      Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  K21b                     Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  K70                      Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  K89                      Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  K116a                    Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  K118c                    Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  K120a                    Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  K121                     Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  96b                      Belgium                     Dog                                           [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  ***E. hirae***                                                                                                                                              
  K51b                     Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  K56b                     Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  K66a                     Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  K73a                     Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  K74b                     Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  K79b                     Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  K115b                    Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  K141                     Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  V70b                     Belgium                     Pig                                           [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  V106c                    Belgium                     Pig                                           [nd]{.smallcaps}   [nd]{.smallcaps}   B                  P. Butaye
  81a                      Belgium                     Dog                                           [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  ***E. casseliflavus***                                                                                                                                      
  86                       Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye
  ***E. gallinarum***                                                                                                                                         
  327                      Belgium                     Chicken                                       [nd]{.smallcaps}   [nd]{.smallcaps}   AB                 P. Butaye

\*CI, Clinical isolate; HO, hospital outbreak; HP, hospitalized patient; CS, community survey. Details are provided for human isolates only.

†Positive for *ccrA*~Ent~ only by Southern hybridization.

###### 

Oligonucleotides used for expression analyses of *ccrAB*~Ent~ genes and for detection/characterization of the *ccrAB*~Ent~ region and detection of enterococcal virulence genes

  **Purpose**                                                                 **Target gene**   **Primer name**   **Sequence (5′--3′)**            **Product size (bp)**   **Reference**
  --------------------------------------------------------------------------- ----------------- ----------------- -------------------------------- ----------------------- ---------------
  Expression study                                                                                                                                                         
                                                                              *ccrA*~Ent~       ccrAFre           AACGATTGACGCAACAAAAGCT           129                     This study
                                                                                                ccrARre           CGCCATAGTACAATGGATTTTTTAGGATAT                           
                                                                                                ccrA~Ent~ probe   TCCGCGAACGTCCTTT                                         
                                                                              *ccrB*~Ent~       ccrBFre           TTTTCTACCACGGCAGTCAAAGAT         68                      This study
                                                                                                ccrBRre           CAATTGATGTAGCGCGCATATTCTA                                
                                                                                                ccrB~Ent~ probe   ACCCTGCATAAATTTT                                         
                                                                              *recA*            recAFre           GATTCAGTTGCTGCTTTAGTTCCA         72                      This study
                                                                                                recARre           CTTGTAACCCGACATGTGAGTCA                                  
                                                                                                recA probe        TTCGCCGTCGATTTC                                          
                                                                              *pbp5*            pbp5Fre           GATCTGGTTTGGAAATGGCTTTTGA        79                      This study
                                                                                                pbp5Rre           CACCGTCTGTATCTGTGATGCTTAA                                
                                                                                                pbp5 probe        TCCCACGAAGATCCTT                                         
                                                                              *adk*             adkFre            CCACGTACGCTAGATCAAGCAA           85                      This study
                                                                                                adkRre            CATGGATATCGATGACAGCATCAATTTT                             
                                                                                                adk probe         ATTGCGTCCAGAGCTT                                         
  *ccrAB*~Ent~ linkage of RT-PCR product and RT-PCR control                                                                                                                
                                                                              *ccrAB*~Ent~      ccrAxF            CGAAAAGCGAAAAGATGAAAAACACAAAGT                           This study
                                                                                                ccrARTR1          ACCTCGATCCGACAAACATGGTCACATAAC   222                     
                                                                                                ccrBxR            ACATAGCCTAAACGTCGTCCACCTG        625                     
                                                                                                ccrBRTR1          TAACCCCACATCATATCGCAACAGTTCCTC   801                     
  PCRs to sequence a part of the genes/CDSs                                                                                                                                
                                                                              *ccrA*~Ent~       ccrAF             GAAATATGAACAAATTCCCCAACG         451                     This study
                                                                                                J03/252ccrARB     TTGAAAAATATAGCGAACAATCC                                  
                                                                              *ccrB*~Ent~       J03/252ccrBF      TCGGAATAAAGGAGCAAGTGTG           525                     This study
                                                                                                ccrBR             GCAGGCGTGAATTTCATTGTA                                    
  Detection in the early phase of the study (later changed for new primers)                                                                                                
                                                                              *ccrA*~Ent~       ccrAF             GAAATATGAACAAATTCCCCAACG         1242                    This study
                                                                                                ccrAR             CGGAAGTAAATCCCACAGACT                                    
                                                                              *ccrB*~Ent~       ccrBF             GGAACCATCGTTTTGATCTACTAG         1321                    This study
                                                                                                ccrBR             GCAGGCGTGAATTTCATTGTA                                    
  New primers used for detection                                                                                                                                           
                                                                              *ccrA*~Ent~       FA                CCATATGGGTATCGTTTAGTGA           453                     This study
                                                                                                RA                AGCTTCGGTCGGTACAATGAT                                    
                                                                              *ccrB*~Ent~       FB                ATTTGTCGCCGACCGATTAAAG           390                     This study
                                                                                                RB                ACGATACAAGGCTTTGAYTTGCT                                  
  Others                                                                                                                                                                   
                                                                              orf1              1259F1            ATTTGTTACTGAATCCAGTGCTTACTC      873                     This study
                                                                                                1259R1            CAATGTTATTCTGCTTGAACTTGACC                               
                                                                              REP factor        1259F2            GCTAGGAGTACAAAATATCCAACGC        721                     This study
                                                                                                1259R2            CTGAATAATTCTCCGTATGAGAGCG                                
                                                                              *tnp*             1259F6            CGAAGCAGCTTAAACGTGGAC            759                     This study
                                                                                                1259R6            GGATATGGTTTCTTTTGGACGC                                   

###### 

Long-range linkage PCR results for the *ccrA*~Ent~ and *ccrB*~Ent~ chromosomal region among 15 *ccrAB*~Ent~-positive *E. faecium* isolates

+, Positive; −, negative; [na]{.smallcaps}, not applicable (one of the genes/CDSs not present); [nd]{.smallcaps}, not determined.

  **Isolate**    **ST\***           **Long-range linkage PCRs**                           
  -------------- ------------------ ----------------------------- ------------------ ---- ------------------
  DO             **18**             \+                            \+                 \+   \+
  E1304          **132**            \+                            \+                 \+   \+
  TUH7-55        **17**             \+                            \+                 \+   \+
  3332           **308**            \+                            \+                 \+   [na]{.smallcaps}
  C68            **16**             \+                            \+                 \+   [na]{.smallcaps}
  E0470          **16**             \+                            \+                 \+   [na]{.smallcaps}
  E0734          **16**             \+                            \+                 \+   [na]{.smallcaps}
  E0745          **16**             \+                            \+                 \+   [na]{.smallcaps}
  TUH7-15        **16**             \+                            \+                 \+   [na]{.smallcaps}
  64/F99/H6      48                 −                             −                  −    [na]{.smallcaps}
  399/F99/A10    310                −                             −                  \+   [na]{.smallcaps}
  399/F99/H8     195                −                             −                  \+   [na]{.smallcaps}
  E1293          50                 [na]{.smallcaps}              [na]{.smallcaps}   \+   [na]{.smallcaps}
  S399/F99/A14   [nd]{.smallcaps}   −                             −                  \+   [na]{.smallcaps}
  S399/S99/A4    [nd]{.smallcaps}   [na]{.smallcaps}              [na]{.smallcaps}   \+   [na]{.smallcaps}

\*STs in bold belong to the CC17 genogroup.

[^1]: †**Present** **address:** Nofima Mat AS, Osloveien 1, N-1430 Ås, Norway.

[^2]: ‡**Present address:** Department of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences, PO Box 5003, N-1432 Ås, Norway.
